Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
YS Biopharma Announces Receipt of Nasdaq Notice
2023-10-26 20:30
HanAll Biopharma Reports Third Quarter 2023 Financial Results and Provides a Business Update
2023-10-26 19:00
Fapon, LASCCO, Abionic Formed Strategic Collaboration for PSP Sepsis Diagnosis in China
2023-10-26 18:33
Biosyngen's BST02, the World's First TIL Therapy for Liver Cancer, is Granted an IND Approval by FDA
2023-10-26 18:18
Bridge Biotherapeutics Announces Positive Recommendation from the Independent Data Monitoring Committee of the BBT-877 Phase 2a Study in Idiopathic Pulmonary Fibrosis
2023-10-26 07:00
First Patient Dosed for MRCT Phase 3 Study on First-Line LS-SCLC of Henlius Anti-PD-1 mAb Serplulimab in Europe
2023-10-25 21:15
FDA Meeting Feedback Puts Turn Biotechnologies on Track to be First Longevity Company Taking Cell Rejuvenation Therapy to Clinic
2023-10-25 20:30
SEH Biotechnology: Revolutionizing the Global Beverage and Brewing Industry with Cutting-Edge Water and Biotech from Taiwan
2023-10-25 18:00
AMS BioteQ Makes Debut at Medical Japan 2023: Bringing Innovative Healthcare into New Horizons
2023-10-25 13:06
GC Cell Joins U.S Cancer Moonshot Project
2023-10-25 11:27
Snapdragon Chemistry, a Cambrex Company, Recognized with CPhI Pharma Award for API Development
2023-10-25 04:18
Cyrus K. Mirsaidi Named Global CEO to Bridgewest Perth Pharma
2023-10-24 23:17
TidetronBioworks Illuminated in Global Spotlight at WFF 2023 for Sustainable Power
2023-10-24 22:31
First Immunotherapy Success in TKI-Resistant Lung Cancer Setting Demonstrates Power of AI-driven Immune Phenotyping by Lunit SCOPE IO - newly published in JCO
2023-10-24 21:00
Phase Ib/II Results of Akeso's PD-1/CTLA-4 Bispecific Antibody for First-Line Treatment of Advanced Hepatocellular Carcinoma Published at 2023 ESMO
2023-10-24 20:00
OBiO Announces Strategic Partnership with Refreshgene to Realize Commercialization of Gene Therapy Product
2023-10-24 12:05
Singapore-based Juniper Biologics Awarded the Most Innovative Oncology Pharmaceutical Company 2023 by GHP Healthcare and Pharmaceutical Awards
2023-10-24 12:00
Cellomics announces Mr. Andy A. Liu as new Group CEO of the Company
2023-10-24 12:00
Alphamab Oncology Announces New Data from Multiple Studies of KN046 with Lung Cancer and Thymic Carcinoma at ESMO
2023-10-24 08:41
LifeSpan Vision Ventures Invests in Matter Bio
2023-10-24 03:40
1
34
35
36
37
38
413